Our study revealed a higher CD28 expression on both CD4+ T cells and CD8+ T cells, and a lower active marker (HLA-DR) expression on total T cells in MSA patients, suggesting a disrupted T cell immunity. Here, CD8A is linked to multiple system atrophy.